All Stories

  1. TcrXY is an acid-sensing two-component transcriptional regulator of Mycobacterium tuberculosis required for persistent infection
  2. Mycobacterium tuberculosis Deficient in PdtaS Cytosolic Histidine Kinase Displays Attenuated Growth and Affords Protective Efficacy against Aerosol M. tuberculosis Infection in Mice
  3. seco-1-Azacubane-2-carboxylic Acid: Derivative Scope and Comparative Biological Evaluation
  4. Synthesis and antibacterial activity of 6″-decanesulfonylacetamide-functionalised amphiphilic derivatives of amikacin and kanamycin
  5. TcrXY is an acid-sensing two-component transcriptional regulator of Mycobacterium tuberculosis and a novel target for enhanced TB therapy
  6. Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria
  7. Discovery of Anti‐tubercular Analogues of Bedaquiline with Modified A‐, B‐ and C‐Ring Subunits
  8. Nitroimidazopyrazinones with Oral Activity against Tuberculosis and Chagas Disease in Mouse Models of Infection
  9. Two‐component sensor histidine kinases of Mycobacterium tuberculosis : Beacons for niche navigation
  10. Mesoporous Silica Nanoparticles Improve Oral Delivery of Antitubercular Bicyclic Nitroimidazoles
  11. Macrophage and neutrophil death programs differentially confer resistance to tuberculosis
  12. Analogues of the Herbicide, N-Hydroxy-N-isopropyloxamate, Inhibit Mycobacterium tuberculosis Ketol-Acid Reductoisomerase and Their Prodrugs Are Promising Anti-TB Drug Leads
  13. The antimicrobial potential of cannabidiol
  14. Discovery of a Pyrimidinedione Derivative with Potent Inhibitory Activity against Mycobacterium tuberculosis Ketol–Acid Reductoisomerase
  15. Synthesis and evaluation of pyridine-derived bedaquiline analogues containing modifications at the A-ring subunit
  16. GPR183 Regulates Interferons, Autophagy, and Bacterial Growth During Mycobacterium tuberculosis Infection and Is Associated With TB Disease Severity
  17. Antitubercular and Antiparasitic 2-Nitroimidazopyrazinones with Improved Potency and Solubility
  18. Human Plasminogen Exacerbates Clostridioides difficile Enteric Disease and Alters the Spore Surface
  19. Structures of fungal and plant acetohydroxyacid synthases
  20. Discovery, Synthesis and Evaluation of a Ketol‐Acid Reductoisomerase Inhibitor
  21. Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering
  22. Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering
  23. Mycobacterium tuberculosis requires glyoxylate shunt and reverse methylcitrate cycle for lactate and pyruvate metabolism
  24. Total Synthesis of the Antimalarial Ascidian Natural Product Albopunctatone
  25. Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity
  26. Pyrrolidine nucleoside bisphosphonates as antituberculosis agents targeting hypoxanthine-guanine phosphoribosyltransferase
  27. Homologous alignment cloning: a rapid, flexible and highly efficient general molecular cloning method
  28. Use of Soluble Extracellular Regions of MmpL (SERoM) as Vaccines for Tuberculosis
  29. PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection
  30. Endopeptidase PepO Regulates the SpeB Cysteine Protease and Is Essential for the Virulence of Invasive M1T1 Streptococcus pyogenes
  31. Thioamide Derivative of the Potent Antitubercular 2-(Decylsulfonyl)acetamide is Less Active Against Mycobacterium tuberculosis, but a More Potent Antistaphylococcal Agent
  32. Isothermal Point Mutation Detection: Toward a First-Pass Screening Strategy for Multidrug-Resistant Tuberculosis
  33. Modifications in the pmrB gene are the primary mechanism for the development of chromosomally encoded resistance to polymyxins in uropathogenic Escherichia coli
  34. The PerR-Regulated P1B-4-Type ATPase (PmtA) Acts as a Ferrous Iron Efflux Pump in Streptococcus pyogenes
  35. Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis
  36. Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models
  37. Saccharomyces cerevisiae Acetohydroxyacid Synthase in complex with bensulfuron methyl
  38. Commercial Herbicides Can Trigger the Oxidative Inactivation of Acetohydroxyacid Synthase
  39. Naked-Eye Colorimetric and Electrochemical Detection of Mycobacterium tuberculosis—toward Rapid Screening for Active Case Finding
  40. Rapid DNA detection of Mycobacterium tuberculosis-towards single cell sensitivity in point-of-care diagnosis
  41. Rapid, Single-Cell Electrochemical Detection of Mycobacterium tuberculosis Using Colloidal Gold Nanoparticles
  42. Host–pathogen interaction during bacterial vaccination
  43. Structures of Mycobacterium tuberculosis 6-oxopurine phosphoribosyltransferase which is a potential target for drug development against this disease
  44. First Crystal Structures of Mycobacterium tuberculosis 6-Oxopurine Phosphoribosyltransferase: Complexes with GMP and Pyrophosphate and with Acyclic Nucleoside Phosphonates Whose Prodrugs Have Antituberculosis Activity
  45. Manganese Homeostasis in Group A Streptococcus Is Critical for Resistance to Oxidative Stress and Virulence
  46. Crystal Structure of E. coli XGPRT in complex with (3R,4S)-4-(Guanin-9-yl)-3-hydroxypyrrolidin-1-N-ylacetylphosphonic acid
  47. ZapE Is a Novel Cell Division Protein Interacting with FtsZ and Modulating the Z-Ring Dynamics
  48. TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines
  49. Inhibition of the Escherichia coli 6-Oxopurine Phosphoribosyltransferases by Nucleoside Phosphonates: Potential for New Antibacterial Agents
  50. Plasmin(ogen) Acquisition by Group A <b><i>Streptococcus</i></b> Protects against C3b-Mediated Neutrophil Killing
  51. Inhibition studies on Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmU)
  52. Host Cell–Induced Components of the Sulfate Assimilation Pathway Are Major Protective Antigens of Mycobacterium tuberculosis
  53. The Secreted Lipoprotein, MPT83, of Mycobacterium tuberculosis Is Recognized during Human Tuberculosis and Stimulates Protective Immunity in Mice
  54. Elucidation ofMycobacterium tuberculosisType II Dehydroquinase Inhibitors using a Fragment Elaboration Strategy
  55. Synthesis and evaluation of M. tuberculosis salicylate synthase (MbtI) inhibitors designed to probe plasticity in the active site
  56. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis
  57. Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads
  58. Immunity toMycobacterium tuberculosis
  59. Synthesis and Evaluation of Potent Ene-yne Inhibitors of Type II Dehydroquinases as Tuberculosis Drug Leads
  60. Tetrahydrolipstatin Inhibition, Functional Analyses, and Three-dimensional Structure of a Lipase Essential for Mycobacterial Viability
  61. Modulation of Shigella virulence in response to available oxygen in vivo
  62. Cutinase-like protein-6 of Mycobacterium tuberculosis is recognised in tuberculosis patients and protects mice against pulmonary infection as a single and fusion protein vaccine
  63. Cutinase‐like proteins of Mycobacterium tuberculosis : characterization of their variable enzymatic functions and active site identification
  64. Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis
  65. Non-motile mini-transposon mutants of Bordetella bronchiseptica exhibit altered abilities to invade and survive in eukaryotic cells
  66. Available carbon source influences the resistance of Neisseria meningitidis against complement
  67. Optimization of Virulence Functions Through Glucosylation of Shigella LPS
  68. Finding your niche: what has been learnt from STM studies on GI colonization
  69. An aromatic amino acid auxotrophic mutant ofBordetella bronchisepticais attenuated and immunogenic in a mouse model of infection
  70. Role of Phosphoglucomutase of Bordetella bronchiseptica in Lipopolysaccharide Biosynthesis and Virulence
  71. Non-motile mini-transposon mutants of Bordetella bronchiseptica exhibit altered abilities to invade and survive in eukaryotic cells